MicroRNA biomarkers in glioblastoma

Journal of Neuro-Oncology

Volumn 114, Issue 1, 2013, Pages 13-23

  Hermansen, Simon Kjær ^a,b   Kristensen, Bjarne Winther ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Biomarker; Glioblastoma; MicroRNA; Review

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 124; MICRORNA 125B; MICRORNA 128; MICRORNA 128A; MICRORNA 149; MICRORNA 153; MICRORNA 154; MICRORNA 155; MICRORNA 15B; MICRORNA 17; MICRORNA 181A; MICRORNA 181B; MICRORNA 181C; MICRORNA 181D; MICRORNA 182; MICRORNA 184; MICRORNA 195; MICRORNA 196A; MICRORNA 196B; MICRORNA 200; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA 323; MICRORNA 328; MICRORNA 330; TEMOZOLOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BIOGENESIS; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; DOWN REGULATION; DRUG RESPONSE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; IN SITU HYBRIDIZATION; MICROARRAY ANALYSIS; NEUROPATHOLOGY; NONHUMAN; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SURVIVAL PREDICTION; UPREGULATION;

BIOLOGICAL MARKERS; BRAIN NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS;

EID: 84881128729     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1155-x     Document Type: Article

References (78)

1. Louis DN, Ohgaki H, Wiestler OD et al (2007) WHO classification of tumours of the central nervous system. International Agency for Research on Cancer, Lyon
2. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459-466
3. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996
4. Zhang W, Zhang J, Hoadley K et al (2012) MiR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression. Neuro Oncol 14(6):712-719
5. Zhi F, Chen X, Wang S et al (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46(9):1640-1649
6. Hermansen SK, Dahlrot RH, Nielsen BS et al (2012) MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. J Neurooncol 111(1):71-81
7. Doleshal M, Magotra AA, Choudhury B et al (2008) Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 10(3):203-211
8. Xi Y, Nakajima G, Gavin E et al (2007) Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13(10):1668-1674
9. Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13(4):271-282
10. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12(12):861-874
11. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10(2):126-139
12. Yi R, Qin Y, Macara IG et al (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17(24):3011-3016
13. Lee Y, Ahn C, Han J et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415-419
14. Kiriakidou M, Nelson P, Lamprinaki S et al (2005) Detection of microRNAs and assays to monitor microRNA activities in vivo and in vitro. Methods Mol Biol 309:295-310
15. Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15(2):188-200
16. Liao JY, Ma LM, Guo YH et al (2010) Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3′ trailers. PLoS ONE 5(5):e10563
17. Place RF, Li LC, Pookot D et al (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105(5):1608-1613
18. Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457(7228):426-433
19. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854
20. Reinhart BJ, Slack FJ, Basson M et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901-906
21. Pasquinelli AE, Reinhart BJ, Slack F et al (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408(6808):86-89
22. Calin GA, Dumitru CD, Shimizu M et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99(24):15524-15529
23. Friedman RC, Farh KK, Burge CB et al (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92-105
24. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10(10):704-714
25. Ciafre SA, Galardi S, Mangiola A et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334(4):1351-1358
26. Niyazi M, Zehentmayr F, Niemöller OM et al (2011) MiRNA expression patterns predict survival in glioblastoma. Radiat Oncol 6:153
27. Guan P, Yin Z, Li X et al (2012) Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 31(1):54
28. Schetter AJ, Harris CC (2011) Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 38(6):734-742
29. Le Quesne J, Caldas C (2010) Micro-RNAs and breast cancer. Mol Oncol 4(3):230-241
30. Fabbri M, Croce CM (2011) Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol 18(4):266-272
31. Lee EJ, Gusev Y, Jiang J et al (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120(5):1046-1054
32. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029-6033
33. Gaur A, Jewell DA, Liang Y et al (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67(6):2456-2468
34. Godlewski J, Nowicki MO, Bronisz A et al (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68(22):9125-9130
35. Silber J, Lim DA, Petritsch C et al (2008) MiR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14
36. Lukiw WJ, Cui JG, Li YY et al (2009) Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM). J Neurooncol 91(1):27-32
37. Sasayama T, Nishihara M, Kondoh T et al (2009) MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 125(6):1407-1413
38. Lavon I, Zrihan D, Granit A et al (2010) Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol 12(5):422-433
39. Lages E, Guttin A, El Atifi M et al (2011) MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes. PLoS ONE 6(5):e20600
40. Lang MF, Yang S, Zhao C et al (2012) Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. PLoS ONE 7(4):e36248
41. Takamizawa J, Konishi H, Yanagisawa K et al (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64(11):3753-3756
42. Guan Y, Mizoguchi M, Yoshimoto K et al (2010) MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res 16(16):4289-4297
43. Jiang L, Mao P, Song L et al (2010) MiR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177(1):29-38
44. Lakomy R, Sana J, Hankeova S et al (2011) MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 102(12):2186-2190
45. Wu Z, Sun L, Wang H et al (2012) MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma. PLoS ONE 7(10):e47270
46. Hegi ME, Liu L, Herman JG et al (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26(25):4189-4199
47. Srinivasan S, Patric IR, Somasundaram K (2011) A ten-microRNA expression signature predicts survival in glioblastoma. PLoS ONE 6(3):e17438
48. Baraniskin A, Kuhnhenn J, Schlegel U et al (2011) Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro Oncol 14(1):29-33
49. Teplyuk NM, Mollenhauer B, Gabriely G et al (2012) MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol 14(6):689-700
50. Malzkorn B, Wolter M, Liesenberg F et al (2009) Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20(3):539-550
51. Rao SA, Santosh V, Somasundaram K (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23(10):1404-1417
52. Li D, Chen P, Li XY et al (2011) Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 15(10):673-682
53. Kim H, Huang W, Jiang X et al (2010) Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci USA 107(5):2183-2188
54. Permuth-Wey J, Thompson RC, Burton Nabors L et al (2011) A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol 105(3):639-646
55. Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513-10518
56. Wang Q, Li P, Li A et al (2012) Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res 31(1):97
57. Ilhan-Mutlu A, Wagner L, Wohrer A et al (2012) Plasma microRNA-21 concentration may be a useful biomarker in glioblastoma patients. Cancer Invest 30(8):615-621
58. Ilhan-Mutlu A, Wagner L, Wohrer A et al (2012) Blood alterations preceding clinical manifestation of glioblastoma. Cancer Invest 30(9):625-629
59. Yang C, Wang C, Chen X et al (2013) Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer 132(1):116-127
60. Li J, Smyth P, Flavin R et al (2007) Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7:36
61. Hall JS, Taylor J, Valentine HR et al (2012) Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation. Br J Cancer 107(4):684-694
62. Aldridge S, Hadfield J (2012) Introduction to miRNA profiling technologies and cross-platform comparison. Methods Mol Biol 822:19-31
63. Git A, Dvinge H, Salmon-Divon M et al (2010) Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16(5):991-1006
64. Jensen SG, Lamy P, Rasmussen MH et al (2011) Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics 12:435
65. Ach RA, Wang H, Curry B (2008) Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol 8:69
66. Chen Y, Gelfond JA, McManus LM et al (2009) Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 10:407
67. Nelson PT, Wang WX, Wilfred BR et al (2008) Technical variables in high-throughput miRNA expression profiling: much work remains to be done. Biochim Biophys Acta 1779(11):758-765
68. Nielsen BS, Jørgensen S, Fog JU et al (2011) High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28(1):27-38
69. Jørgensen S, Baker A, Møller S et al (2010) Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52(4):375-381
70. Sempere LF, Preis M, Yezefski T et al (2010) Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered microRNA expression in solid tumors. Clin Cancer Res 16(16):4246-4255
71. Rask L, Balslev E, Jørgensen S et al (2011) High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 119(10):663-673
72. Wienholds E, Kloosterman WP, Miska E et al (2005) MicroRNA expression in zebrafish embryonic development. Science 309(5732):310-311
73. Kloosterman WP, Wienholds E, de Bruijn E et al (2006) In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods 3(1):27-29
74. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10(1):57-63
75. Weng L, Wu X, Gao H et al (2010) MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 222(1):41-51
76. Schulte JH, Marschall T, Martin M et al (2010) Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Res 38(17):5919-5928
77. Fang X, Yoon JG, Li L et al (2011) The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics 12:11
78. Weller M, Stupp R, Reifenberger G et al (2010) MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 6(1):39-51